This study presents Bacillus subtilis T7 as the first known strain of B. subtilis capable of simultaneous lignin depolymerization and direct hydrogen production—a dual metabolic capability not previously reported in this species. B. subtilis T7 demonstrated 63.38% lignin degradation and 56.53% Azure B decolorization over seven days, with HPLC detection of aromatic intermediates—ferulic acid (0.85 mg/L) and vanillin (0.666 mg/L)—confirming active lignin catabolism. Agar-based assays revealed robust hydrolytic enzyme activities, including proteases (23.3 mm), cellulases (24.5 mm), amylases (14.2 mm), and xylanases (11.6 mm), surpassing those of many reported Bacillus strains. Whole-genome analysis confirmed a cascade of carbohydrate-active enzymes (CAZymes) including AA10 (lytic polysaccharide monooxygenases), AA3 (oxidoreductases), AA6 (quinone reductases), and CE1 (acetyl xylan esterases). These enzymes are associated with enhanced cellulolytic and xylanolytic activities, as well as increased lignin degradation. Batch fermentation experiments demonstrated that B. subtilis T7 produced hydrogen yields ranging from 0.53 to 1.41 mol H₂/mol substrate across various feedstocks, including xylose, glucose, carboxymethyl cellulose (CMC), starch, and untreated food waste. Xylose exhibited the highest volumetric productivity, achieving 274 mL H₂/g volatile solids, along with the most rapid production kinetics, indicating efficient metabolic utilization of this pentose sugar. In contrast, untreated food waste yielded the maximum molar hydrogen output of 1.41 mol H₂/mol substrate, attributable to its heterogeneous carbohydrate composition and lower average molecular weight, which likely enhanced enzymatic accessibility and substrate solubilization. These findings indicate that B. subtilis T7 encodes a functional [FeFe]-hydrogenase operon, along with an expanded repertoire of oxidative CAZymes, enabling it to bioprocess waste biomass into hydrogen without the need for syntrophic partners.
• B. subtilis T7 show dual potential for lignin degradation and hydrogen production.
• The genome contains CAZymes (AA10, AA3, AA6, CE1) responsible for lignocellulose deconstruction.
• The strain T7 produced a hydrogen yield of 1.411 mol H₂/mol substrate from xylose.
这项研究表明枯草芽孢杆菌T7是已知的第一个能够同时解聚木质素和直接产氢的枯草芽孢杆菌菌株,这是该物种以前没有报道过的双重代谢能力。枯草芽孢杆菌T7在7天内对木质素的降解率为63.38%,对Azure B的脱色率为56.53%,HPLC检测了芳香族中间体阿魏酸(0.85 mg/L)和香兰素(0.666 mg/L),证实了活性木质素分解代谢。以木脂为基础的分析显示,水解酶活性强劲,包括蛋白酶(23.3 mm)、纤维素酶(24.5 mm)、淀粉酶(14.2 mm)和木聚糖酶(11.6 mm),超过了许多报道的芽孢杆菌菌株。全基因组分析证实了一系列碳水化合物活性酶(CAZymes),包括AA10(水解多糖单加氧酶)、AA3(氧化还原酶)、AA6(醌还原酶)和CE1(乙酰木聚糖酯酶)。这些酶与增强的纤维素分解和木聚糖分解活性以及增加的木质素降解有关。批量发酵实验表明,枯草芽孢杆菌T7在各种原料下产生的氢气产率为0.53至1.41 mol H₂/mol底物,包括木糖、葡萄糖、羧甲基纤维素(CMC)、淀粉和未经处理的食物垃圾。木糖表现出最高的体积产率,达到274 mL H 2 /g挥发性固体,以及最快的生产动力学,表明这种戊糖的代谢利用效率很高。相比之下,未经处理的食物垃圾产生的最大摩尔氢产量为1.41 mol H₂/mol底物,这是由于其碳水化合物的异质性和较低的平均分子量,这可能增强了酶的可及性和底物的溶解性。这些发现表明,枯草芽孢杆菌T7编码一个功能性的[FeFe]-氢化酶操纵子,以及一个扩展的氧化酶库,使其能够在不需要合作伙伴的情况下将废弃生物质生物加工成氢。•枯草芽孢杆菌T7具有木质素降解和产氢的双重潜力。•基因组包含负责木质纤维素解构的CAZymes (AA10, AA3, AA6, CE1)。•菌株T7从木糖中提取的底物产氢量为1.411 mol H 2 /mol。
{"title":"Bacillus subtilis T7 encodes [FeFe]-hydrogenase and lignin-targeting LPMOs for consolidated bioprocessing","authors":"Waqar Iqbal, Hongzhen Cai, Zhihe Li, Jiankang Zhang, Keyan Yang, Xiangsheng Han, Dongye Chuancheng, Andong Zhang, Yasir Anwar, Ihsan Ullah, Tawaf Ali Shah","doi":"10.1007/s00253-025-13687-9","DOIUrl":"10.1007/s00253-025-13687-9","url":null,"abstract":"<p>This study presents <i>Bacillus subtilis</i> T7 as the first known strain of <i>B. subtilis</i> capable of simultaneous lignin depolymerization and direct hydrogen production—a dual metabolic capability not previously reported in this species. <i>B. subtilis</i> T7 demonstrated 63.38% lignin degradation and 56.53% Azure B decolorization over seven days, with HPLC detection of aromatic intermediates—ferulic acid (0.85 mg/L) and vanillin (0.666 mg/L)—confirming active lignin catabolism. Agar-based assays revealed robust hydrolytic enzyme activities, including proteases (23.3 mm), cellulases (24.5 mm), amylases (14.2 mm), and xylanases (11.6 mm), surpassing those of many reported <i>Bacillus</i> strains. Whole-genome analysis confirmed a cascade of carbohydrate-active enzymes (CAZymes) including AA10 (lytic polysaccharide monooxygenases), AA3 (oxidoreductases), AA6 (quinone reductases), and CE1 (acetyl xylan esterases). These enzymes are associated with enhanced cellulolytic and xylanolytic activities, as well as increased lignin degradation. Batch fermentation experiments demonstrated that <i>B. subtilis</i> T7 produced hydrogen yields ranging from 0.53 to 1.41 mol H₂/mol substrate across various feedstocks, including xylose, glucose, carboxymethyl cellulose (CMC), starch, and untreated food waste. Xylose exhibited the highest volumetric productivity, achieving 274 mL H₂/g volatile solids, along with the most rapid production kinetics, indicating efficient metabolic utilization of this pentose sugar. In contrast, untreated food waste yielded the maximum molar hydrogen output of 1.41 mol H₂/mol substrate, attributable to its heterogeneous carbohydrate composition and lower average molecular weight, which likely enhanced enzymatic accessibility and substrate solubilization. These findings indicate that <i>B. subtilis</i> T7 encodes a functional [FeFe]-hydrogenase operon, along with an expanded repertoire of oxidative CAZymes, enabling it to bioprocess waste biomass into hydrogen without the need for syntrophic partners.</p><p><i>• B. subtilis T7 show dual potential for lignin degradation and hydrogen production.</i></p><p><i>• The genome contains CAZymes (AA10, AA3, AA6, CE1) responsible for lignocellulose deconstruction.</i></p><p><i>• The strain T7 produced a hydrogen yield of 1.411 mol H₂/mol substrate from xylose.</i></p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.3,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-025-13687-9.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145958798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-12DOI: 10.1007/s00253-025-13651-7
Paweł Mitkowski, Elżbieta Jagielska, Małgorzata Korzeniowska nee Wiweger, Marzena Nowacka, Morten Kjos, Christian Kranjec, Izabela Sabała
Spread of antimicrobial resistance and lack of new antibiotics have brought attention to alternative strategies of combating pathogenic bacteria. One of these strategies takes advantage of the bacteriolytic activity of peptidoglycan hydrolases. The enzymes allow efficient elimination of pathogenic bacteria while preserving the natural microflora. Such enzymes must meet specific criteria of activity, stability, and safety to become efficient enzybiotics. In our previous work (10.1128/spectrum.03546-23), we have created three chimeric enzymes and demonstrated their high efficacy in the elimination of Enterococcus faecalis and Staphylococcus aureus. In this work, we investigated and addressed issues related to the stability and safety of these enzymes. To improve the stability, we engineered the linkers and optimized storage conditions. Moreover, we demonstrated that such enzymes do not have any cytotoxic effects on eukaryotic cells, Danio rerio or Galleria mellonella. We also investigated the prevalence of resistance development, a particularly important feature for new antimicrobials. In conclusion, we here propose efficient, safe, and stable chimeric enzybiotics to eliminate E. faecalis and S. aureus.
{"title":"Enhancing stability and safety of chimeric peptidoglycan hydrolases by linker engineering","authors":"Paweł Mitkowski, Elżbieta Jagielska, Małgorzata Korzeniowska nee Wiweger, Marzena Nowacka, Morten Kjos, Christian Kranjec, Izabela Sabała","doi":"10.1007/s00253-025-13651-7","DOIUrl":"10.1007/s00253-025-13651-7","url":null,"abstract":"<p>Spread of antimicrobial resistance and lack of new antibiotics have brought attention to alternative strategies of combating pathogenic bacteria. One of these strategies takes advantage of the bacteriolytic activity of peptidoglycan hydrolases. The enzymes allow efficient elimination of pathogenic bacteria while preserving the natural microflora. Such enzymes must meet specific criteria of activity, stability, and safety to become efficient enzybiotics. In our previous work (10.1128/spectrum.03546-23), we have created three chimeric enzymes and demonstrated their high efficacy in the elimination of <i>Enterococcus faecalis</i> and <i>Staphylococcus aureus</i>. In this work, we investigated and addressed issues related to the stability and safety of these enzymes. To improve the stability, we engineered the linkers and optimized storage conditions. Moreover, we demonstrated that such enzymes do not have any cytotoxic effects on eukaryotic cells, <i>Danio rerio</i> or <i>Galleria mellonella</i>. We also investigated the prevalence of resistance development, a particularly important feature for new antimicrobials. In conclusion, we here propose efficient, safe, and stable chimeric enzybiotics to eliminate <i>E. faecalis</i> and <i>S. aureus</i>.</p><p>• <i>Optimized linker design enhances enzyme stability.</i></p><p>• <i>Generated chimeric lysins do not display cytotoxicity.</i></p><p>• <i>Chimeras with minimal risk of resistance development were selected.</i></p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.3,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-025-13651-7.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145958713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-12DOI: 10.1007/s00253-025-13689-7
Islam M. Ahmady, Javad B. M. Parambath, Elsiddig A. E. Elsheikh, Gwangmin Kim, Changseok Han, Alejandro Pérez García, Ahmed A. Mohamed
The current study investigated 17 bacterial strains for their ability to synthesize gold nanoparticles (AuNPs) from the aryldiazonium gold(III) salt (DS-AuCl4). The study aims to investigate the ability of bacterial cell biomass in the stationary phase of growth to synthesize AuNPs at 28 °C and 37 °C. Eleven bacterial strains were isolated from soil and identified using the VITEK® 2 system and 16S rRNA sequencing. An additional six strains were obtained from the American Type Culture Collection (ATCC). The investigated Gram-positive and Gram-negative bacterial strains successfully produced anisotropic AuNPs at a cell density of 2.0 McFarland (6.0 × 108 CFU/mL). Nanoparticle formation was faster when samples were incubated at 37 °C than at 28 °C across all bacterial strains. The results of UV-vis spectroscopy confirmed the presence of AuNPs, with peaks observed centered at 550 nm. High-resolution transmission electron microscopy (HR-TEM) revealed a variety of morphologies, including spheres, rods, triangles, pentagons, hexagons, irregular shapes, and flower-like structures. Gram-positive and Gram-negative bacteria synthesized AuNPs of sizes 38.7 ± 26.0 and 34.0 ± 18.6 nm, respectively. Lattice-spacing analysis confirmed the formation of metallic AuNPs. Energy-dispersed X-ray spectroscopy (EDS) validated the presence of gold in the samples, and X-ray photoelectron spectroscopy (XPS) confirmed the elemental composition of AuNPs at 84.0 eV. These nanoparticles have potential applications in cancer therapy and diagnosis, antibacterial treatments, and drug delivery.
• The AuNPs were synthesized using various bacterial strains
• The gold precursor is aryldiazonium gold(III) salt
{"title":"Investigating soil and ATCC bacterial strains for their ability to synthesize anisotropic gold nanoparticles","authors":"Islam M. Ahmady, Javad B. M. Parambath, Elsiddig A. E. Elsheikh, Gwangmin Kim, Changseok Han, Alejandro Pérez García, Ahmed A. Mohamed","doi":"10.1007/s00253-025-13689-7","DOIUrl":"10.1007/s00253-025-13689-7","url":null,"abstract":"<p>The current study investigated 17 bacterial strains for their ability to synthesize gold nanoparticles (AuNPs) from the aryldiazonium gold(III) salt (DS-AuCl<sub>4</sub>). The study aims to investigate the ability of bacterial cell biomass in the stationary phase of growth to synthesize AuNPs at 28 °C and 37 °C. Eleven bacterial strains were isolated from soil and identified using the VITEK® 2 system and 16S rRNA sequencing. An additional six strains were obtained from the American Type Culture Collection (ATCC). The investigated Gram-positive and Gram-negative bacterial strains successfully produced anisotropic AuNPs at a cell density of 2.0 McFarland (6.0 × 10<sup>8</sup> CFU/mL). Nanoparticle formation was faster when samples were incubated at 37 °C than at 28 °C across all bacterial strains. The results of UV-vis spectroscopy confirmed the presence of AuNPs, with peaks observed centered at 550 nm. High-resolution transmission electron microscopy (HR-TEM) revealed a variety of morphologies, including spheres, rods, triangles, pentagons, hexagons, irregular shapes, and flower-like structures. Gram-positive and Gram-negative bacteria synthesized AuNPs of sizes 38.7 ± 26.0 and 34.0 ± 18.6 nm, respectively. Lattice-spacing analysis confirmed the formation of metallic AuNPs. Energy-dispersed X-ray spectroscopy (EDS) validated the presence of gold in the samples, and X-ray photoelectron spectroscopy (XPS) confirmed the elemental composition of AuNPs at 84.0 eV. These nanoparticles have potential applications in cancer therapy and diagnosis, antibacterial treatments, and drug delivery.</p><p>• <i>The AuNPs were synthesized using various bacterial strains</i></p><p>• <i>The gold precursor is aryldiazonium gold(III) salt</i></p><p>• <i>Various anisotropic morphologies were obtained</i></p><p>Created in BioRender. Ahmady, I. (2025)</p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.3,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-025-13689-7.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145958721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-12DOI: 10.1007/s00253-025-13690-0
Jung-Ah Cho, Sang-Soo Jeon, Go Woon Choi, Chang-Hun Lee, Sung-Jae Kim
Extracellular membrane vesicles (EVs) are nanosized particles that contain various molecules originating from their parental cells and are produced by all three domains of life, including bacteria. Bacterial EVs are known to contribute to bacterial infections and immune responses in various human diseases. Enterococcus faecalis is an opportunistic pathogen. In this study, we examined the physical and physiological properties of EVs generated by E. faecalis, including particle size, protein composition, and cytokine-inducing profiles. To this end, we isolated EVs from bacteria under different preparation processes, and also a certain condition with the addition of EGCG. First, the bacterial culture supernatants were directly ultracentrifuged (named “Rough”), or filtered through 0.45- or 0.22 µm pore-sized membrane filters (named as “0.45 µm” or “0.22 µm,” respectively). EVs from EGCG-treated bacteria were prepared using a 0.45 µm pore-sized membrane filter and named “EGCG + 0.45 µm.” Each EV sample was subjected to DLS, SDS-PAGE, and cytokine array analyses. DLS results showed that the differently prepared EVs had distinct size distributions depending on the filtration process. SDS-PAGE results revealed unique protein profiles that differentiated EVs under each condition. Treatment of macrophages with each EV sample markedly increased cell viability and size. The cytokine profiles produced by macrophages in response to each EV preparation revealed both common and distinguishable factors. This study has significance in revealing aspects of the biological characteristics of EVs produced by E. faecalis, which have previously been largely unknown.
{"title":"Investigation on physical and physiological properties of extracellular vesicles derived from Enterococcus faecalis","authors":"Jung-Ah Cho, Sang-Soo Jeon, Go Woon Choi, Chang-Hun Lee, Sung-Jae Kim","doi":"10.1007/s00253-025-13690-0","DOIUrl":"10.1007/s00253-025-13690-0","url":null,"abstract":"<div><p>Extracellular membrane vesicles (EVs) are nanosized particles that contain various molecules originating from their parental cells and are produced by all three domains of life, including bacteria. Bacterial EVs are known to contribute to bacterial infections and immune responses in various human diseases. <i>Enterococcus faecalis</i> is an opportunistic pathogen. In this study, we examined the physical and physiological properties of EVs generated by <i>E. faecalis</i>, including particle size, protein composition, and cytokine-inducing profiles. To this end, we isolated EVs from bacteria under different preparation processes, and also a certain condition with the addition of EGCG. First, the bacterial culture supernatants were directly ultracentrifuged (named “Rough”), or filtered through 0.45- or 0.22 µm pore-sized membrane filters (named as “0.45 µm” or “0.22 µm,” respectively). EVs from EGCG-treated bacteria were prepared using a 0.45 µm pore-sized membrane filter and named “EGCG + 0.45 µm.” Each EV sample was subjected to DLS, SDS-PAGE, and cytokine array analyses. DLS results showed that the differently prepared EVs had distinct size distributions depending on the filtration process. SDS-PAGE results revealed unique protein profiles that differentiated EVs under each condition. Treatment of macrophages with each EV sample markedly increased cell viability and size. The cytokine profiles produced by macrophages in response to each EV preparation revealed both common and distinguishable factors. This study has significance in revealing aspects of the biological characteristics of EVs produced by <i>E. faecalis</i>, which have previously been largely unknown.</p></div>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.3,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-025-13690-0.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145958717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-12DOI: 10.1007/s00253-025-13679-9
Kian Ghaempanah, Hengrui Zhou, Sang Yup Lee
Malonyl-CoA serves as a central precursor for the biosynthesis of diverse high-value compounds, including lipids, organic acids, and polyketides, in engineered microbial fermentation systems. However, insufficient malonyl-CoA supply often limits the production of these products. Intracellular malonyl-CoA levels are tightly regulated by the activities of acetyl-CoA carboxylase (ACC) and fatty acid synthesis pathway enzymes. Although strategies have been developed to redirect malonyl-CoA flux from fatty acid biosynthesis toward desired products, native ACC-mediated synthesis remains constrained by slow kinetics, complex regulation, and ATP consumption. To overcome these limitations, two alternative malonyl-CoA biosynthetic pathways have recently been developed. The malonate assimilation pathway enables direct uptake and CoA ligation of exogenous malonate, providing precise control over malonyl-CoA metabolism. The non-carboxylative malonyl-CoA (NCM) pathway converts pyruvate to malonyl-CoA through a novel intermediate, eliminating both ATP and CO2 loss while simultaneously regenerating NADPH. This review highlights recent advances in these two alternative malonyl-CoA biosynthetic pathways and their applications across diverse microbial hosts, underscoring their potential to enhance the sustainable production of valuable biochemicals.
{"title":"Alternative malonyl-CoA pathways for microbial production of diverse products","authors":"Kian Ghaempanah, Hengrui Zhou, Sang Yup Lee","doi":"10.1007/s00253-025-13679-9","DOIUrl":"10.1007/s00253-025-13679-9","url":null,"abstract":"<div><p>Malonyl-CoA serves as a central precursor for the biosynthesis of diverse high-value compounds, including lipids, organic acids, and polyketides, in engineered microbial fermentation systems. However, insufficient malonyl-CoA supply often limits the production of these products. Intracellular malonyl-CoA levels are tightly regulated by the activities of acetyl-CoA carboxylase (ACC) and fatty acid synthesis pathway enzymes. Although strategies have been developed to redirect malonyl-CoA flux from fatty acid biosynthesis toward desired products, native ACC-mediated synthesis remains constrained by slow kinetics, complex regulation, and ATP consumption. To overcome these limitations, two alternative malonyl-CoA biosynthetic pathways have recently been developed. The malonate assimilation pathway enables direct uptake and CoA ligation of exogenous malonate, providing precise control over malonyl-CoA metabolism. The non-carboxylative malonyl-CoA (NCM) pathway converts pyruvate to malonyl-CoA through a novel intermediate, eliminating both ATP and CO<sub>2</sub> loss while simultaneously regenerating NADPH. This review highlights recent advances in these two alternative malonyl-CoA biosynthetic pathways and their applications across diverse microbial hosts, underscoring their potential to enhance the sustainable production of valuable biochemicals.</p></div>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.3,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-025-13679-9.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145958738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Limited research has explored the relationship between microbiota characteristics in both the oral cavity and the intestine, and the prevalence of obesity or overweight status in preschool-aged children. In this study, we collected saliva, oral mucosal plaque, supragingival dental plaque, and fecal samples from 47 preschool children aged 3 to 6 with obesity/overweight, along with 34 age-matched normal-weight controls. These samples were subjected to 16S rRNA gene sequencing for microbial analysis. We found that the overweight/obesity group exhibited a lower richness and diversity of fecal microbiota compared to the control group. Distinct niche-specific clustering was observed across different oral niches. In the overweight/obesity group, five genera showed significantly higher abundance, while six genera showed significantly lower levels in saliva samples. In mucosal samples, five genera exhibited increased abundance, whereas two genera had reduced levels in dental plaque samples. In fecal samples, two genera displayed significantly higher abundance, while eight genera showed lower levels. These distinct microbial taxa were also correlated with clinical parameters, including body mass index (BMI) and skin-fold thickness (SFT). Furthermore, correlation analysis showed that the oral bacteria were significantly negatively correlated with fecal bacteria, which was markedly attenuated in children with overweight/obesity. Overall, our study identifies distinct microbial signatures in the oral cavity and intestine of preschool children with overweight/obesity, compared to those with normal weight. These findings offer new insights into the potential role of microbial dysbiosis in the development of childhood obesity, providing a foundation for future strategies aimed at preventing and intervening in childhood obesity and overweight.
• Distinct niche-specific clustering was observed between different oral niches.
• Shifts of abundance observed in obese children were correlated with BMI and SFT.
• Negative correlations between oral and fecal genera were weaker in overweight/obese children.
{"title":"Distinct oral and fecal microbiota composition in preschool children with overweight/obesity: a cross-sectional study","authors":"Hanguo Feng, Xinyi Zeng, Siyuan Yu, Qi Sun, Guiding Li, Yanhong Li, Juan Liu, Nanquan Rao","doi":"10.1007/s00253-025-13685-x","DOIUrl":"10.1007/s00253-025-13685-x","url":null,"abstract":"<p>Limited research has explored the relationship between microbiota characteristics in both the oral cavity and the intestine, and the prevalence of obesity or overweight status in preschool-aged children. In this study, we collected saliva, oral mucosal plaque, supragingival dental plaque, and fecal samples from 47 preschool children aged 3 to 6 with obesity/overweight, along with 34 age-matched normal-weight controls. These samples were subjected to 16S rRNA gene sequencing for microbial analysis. We found that the overweight/obesity group exhibited a lower richness and diversity of fecal microbiota compared to the control group. Distinct niche-specific clustering was observed across different oral niches. In the overweight/obesity group, five genera showed significantly higher abundance, while six genera showed significantly lower levels in saliva samples. In mucosal samples, five genera exhibited increased abundance, whereas two genera had reduced levels in dental plaque samples. In fecal samples, two genera displayed significantly higher abundance, while eight genera showed lower levels. These distinct microbial taxa were also correlated with clinical parameters, including body mass index (BMI) and skin-fold thickness (SFT). Furthermore, correlation analysis showed that the oral bacteria were significantly negatively correlated with fecal bacteria, which was markedly attenuated in children with overweight/obesity. Overall, our study identifies distinct microbial signatures in the oral cavity and intestine of preschool children with overweight/obesity, compared to those with normal weight. These findings offer new insights into the potential role of microbial dysbiosis in the development of childhood obesity, providing a foundation for future strategies aimed at preventing and intervening in childhood obesity and overweight.</p><p>• <i>Distinct niche-specific clustering was observed between different oral niches.</i></p><p>• <i>Shifts of abundance observed in obese children were correlated with BMI and SFT.</i></p><p>• <i>Negative correlations between oral and fecal genera were weaker in overweight/obese children.</i></p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.3,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-025-13685-x.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145958752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-10DOI: 10.1007/s00253-025-13681-1
Jana Senger, Mario Keutgen, Nicole Roth, Ines Seitl, Lutz Fischer
Protein-glutamine glutaminases (PGs; EC 3.5.1.44) have gained attention in the food industry due to their application in plant protein products. The recently discovered PG from Bacteroides helcogenes (PGB) has especially been shown to provide promising characteristics for improving the techno-functional properties of plant proteins. A prerequisite for food enzymes, such as the PG, is their production with an expression host that meets food safety and yield requirements. The antibiotic-free and secretory production of the PGB was targeted in this study using the undomesticated Bacillus subtilis 007. The CRISPR/Cas9-mediated approach enabled specific genomic PGB integrations, while simultaneously deleting unwanted B. subtilis traits. Firstly, the PGB expression cassette was integrated into the sigF gene, leading to an asporogenic strain and extracellular activity of 4.1 µkat/Lculture in bioreactor cultivations. However, excessive foaming hampered the production process tremendously. Consequently, a second PGB copy was integrated into the sfp locus, which is involved in the production of lipopeptides, such as surfactin. As a result, the PGB activity was increased to 5.4 µkat/Lculture, and foaming during cultivation was reduced significantly. The introduction of a third PGB copy for preventing cell motility did not increase production; however, the integration into the well-established amyE locus improved the PGB yield during reactor cultivations. A final extracellular activity of 9.5 µkat/Lculture was reached. The multiple genomic integrations of the PGB gene enabled the efficient PGB secretion in an optimized B. subtilis host without the need for antibiotics.
• Site-specific PGB integration enabled by genome sequencing of B. subtilis 007.
• Antibiotic-free and secretory PGB production with an optimized B. subtilis host.
• Increased PGB production reaching 9.5 µkat/Lculture.
{"title":"Toward food-grade production of the Bacteroides helcogenes protein-glutamine glutaminase with an optimized Bacillus subtilis strain","authors":"Jana Senger, Mario Keutgen, Nicole Roth, Ines Seitl, Lutz Fischer","doi":"10.1007/s00253-025-13681-1","DOIUrl":"10.1007/s00253-025-13681-1","url":null,"abstract":"<p>Protein-glutamine glutaminases (PGs; EC 3.5.1.44) have gained attention in the food industry due to their application in plant protein products. The recently discovered PG from <i>Bacteroides helcogenes</i> (PGB) has especially been shown to provide promising characteristics for improving the techno-functional properties of plant proteins. A prerequisite for food enzymes, such as the PG, is their production with an expression host that meets food safety and yield requirements. The antibiotic-free and secretory production of the PGB was targeted in this study using the undomesticated <i>Bacillus subtilis</i> 007. The CRISPR/Cas9-mediated approach enabled specific genomic PGB integrations, while simultaneously deleting unwanted <i>B. subtilis</i> traits. Firstly, the PGB expression cassette was integrated into the <i>sigF</i> gene, leading to an asporogenic strain and extracellular activity of 4.1 µkat/L<sub>culture</sub> in bioreactor cultivations. However, excessive foaming hampered the production process tremendously. Consequently, a second PGB copy was integrated into the <i>sfp</i> locus, which is involved in the production of lipopeptides, such as surfactin. As a result, the PGB activity was increased to 5.4 µkat/L<sub>culture</sub>, and foaming during cultivation was reduced significantly. The introduction of a third PGB copy for preventing cell motility did not increase production; however, the integration into the well-established <i>amyE</i> locus improved the PGB yield during reactor cultivations. A final extracellular activity of 9.5 µkat/L<sub>culture</sub> was reached. The multiple genomic integrations of the PGB gene enabled the efficient PGB secretion in an optimized <i>B. subtilis</i> host without the need for antibiotics.</p><p><i>• Site-specific PGB integration enabled by genome sequencing of B. subtilis 007</i>.</p><p><i>• Antibiotic-free and secretory PGB production with an optimized B. subtilis host</i>.</p><p><i>• Increased PGB production reaching 9.5 µkat/L</i><sub>culture</sub>.</p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.3,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12791059/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145948557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-10DOI: 10.1007/s00253-025-13647-3
Shivani Adhvaryu, Jana Kiskova, Maria Piknova, Veronika Farkasova, Iva Buchtikova, Xenie Kourilova, Martin Kizovsky, Marketa Benesova, Ota Samek, Stanislav Obruca, Peter Pristas
Since plastics pose the greatest threat to humanity, it is essential to find an economic and sustainable solution to combat environmental pollution. In this study, the ability of polyhydroxyalkanoates (PHA) production by the halophilic bacterium Halovirbrio sp. HP20-59 in the presence of different carbon sources was examined. The strain showed a selective substrate preference, with the highest PHA production (reaching up to 73% of cell dry weight) in the presence of galactose, while fructose, arabinose, glycerol and xylose resulted in lower accumulation. Phylogenetic analysis based on the 16S rRNA gene sequence and whole-genome sequencing confirmed the HP20-59 strain as a novel species within the Oceanospirillales order. Draft genome showed a size of 4,165,370 bp with a GC content of 55.1% and a complete set of pha genes. The comparative analysis of the phaC gene identified a 638 amino acid-long class I poly(R)-hydroxyalkanoic acid synthase, showing 91% similarity to Halovibrio variabilis and 89% similarity to species within the Vreelandella genus, suggesting a possible horizontal gene transfer of the pha gene cluster. These findings highlight the unique genetic and metabolic characteristics of Halovibrio sp. HP20-59, making it a promising candidate for industrial PHA production and a valuable resource for research on sustainable biopolymers.
{"title":"Genome sequence of Halovibrio sp. HP20-59 as a promising polyhydroxybutyrate producer","authors":"Shivani Adhvaryu, Jana Kiskova, Maria Piknova, Veronika Farkasova, Iva Buchtikova, Xenie Kourilova, Martin Kizovsky, Marketa Benesova, Ota Samek, Stanislav Obruca, Peter Pristas","doi":"10.1007/s00253-025-13647-3","DOIUrl":"10.1007/s00253-025-13647-3","url":null,"abstract":"<p>Since plastics pose the greatest threat to humanity, it is essential to find an economic and sustainable solution to combat environmental pollution. In this study, the ability of polyhydroxyalkanoates (PHA) production by the halophilic bacterium <i>Halovirbrio</i> sp. HP20-59 in the presence of different carbon sources was examined. The strain showed a selective substrate preference, with the highest PHA production (reaching up to 73% of cell dry weight) in the presence of galactose, while fructose, arabinose, glycerol and xylose resulted in lower accumulation. Phylogenetic analysis based on the 16S rRNA gene sequence and whole-genome sequencing confirmed the HP20-59 strain as a novel species within the <i>Oceanospirillales</i> order. Draft genome showed a size of 4,165,370 bp with a GC content of 55.1% and a complete set of <i>pha</i> genes. The comparative analysis of the <i>phaC</i> gene identified a 638 amino acid-long class I poly(R)-hydroxyalkanoic acid synthase, showing 91% similarity to <i>Halovibrio variabilis</i> and 89% similarity to species within the <i>Vreelandella</i> genus, suggesting a possible horizontal gene transfer of the <i>pha</i> gene cluster. These findings highlight the unique genetic and metabolic characteristics of <i>Halovibrio</i> sp. HP20-59, making it a promising candidate for industrial PHA production and a valuable resource for research on sustainable biopolymers.</p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.3,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12791064/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145948487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-10DOI: 10.1007/s00253-025-13699-5
Salma Banu. A, Jaya Lakshmi. S. S., Leela K. V., K. Mani Rahulan, Kaviyarasan. S
Multidrug-resistant (MDR) Pseudomonas aeruginosa poses a critical challenge in clinical settings because of its resistance to conventional antibiotics. This study investigated the antibacterial potential of silica-coated silver nanoparticles (SiO₂@AgNPs) against MDR P. aeruginosa and explored their synergistic interactions with selected antibiotics. A total of 450 pus samples were processed for bacterial isolation, and P. aeruginosa was identified using standard microbiological methods. MDR strains were confirmed using MIC-based VITEK antimicrobial susceptibility testing and RT-PCR for resistance genes. The antibacterial activity of the SiO₂@AgNPs was assessed using the microbroth dilution method. A checkerboard assay was conducted against MDR isolates to determine the synergy between SiO₂@AgNPs and ciprofloxacin, meropenem, and ceftazidime-avibactam. The synthesized nanoparticles were characterized using transmission electron microscopy (TEM), Fourier-transform infrared (FTIR) spectroscopy, and X-ray diffraction (XRD) analysis. Of the 450 pus samples, 100 P. aeruginosa isolates were identified, of which 13 were classified as MDR P. aeruginosa. SiO₂@AgNPs exhibited effective antibacterial activity, with an MIC of 500 µg/mL against MDR P. aeruginosa. Checkerboard assays demonstrated strong synergy with meropenem and ceftazidime-avibactam (FICI = 0.375) and partial synergy with ciprofloxacin (FICI = 0.625–1.0625). TEM revealed spherical particles with an average size of 10 nm, FTIR confirmed SiO₂ functional groups, and XRD revealed crystalline silver nanoparticles within an amorphous silica matrix. These findings indicate that SiO₂@AgNPs possess potent antibacterial activity against MDR P. aeruginosa and can enhance the efficacy of certain antibiotics, highlighting their potential in combination therapy against resistant strains.
● Silica-coated silver nanoparticles effectively inhibited MDR P. aeruginosa.
● SiO₂@AgNPs enhance the efficacy of meropenem and ceftazidime-avibactam.
● Nanoparticle-antibiotic combinations may offer new strategies for treating resistant infections.
耐多药铜绿假单胞菌由于对常规抗生素具有耐药性,对临床环境提出了严峻的挑战。本研究考察了二氧化硅包覆银纳米颗粒(SiO₂@AgNPs)对耐多药铜绿假单胞菌(MDR P. aeruginosa)的抗菌潜力,并探讨了它们与选定抗生素的协同作用。对450份脓液样本进行细菌分离处理,采用标准微生物学方法对铜绿假单胞菌进行鉴定。采用基于mic的VITEK药敏试验和RT-PCR检测耐药基因,对MDR菌株进行确证。采用微肉汤稀释法对SiO₂@AgNPs的抗菌活性进行了评价。对MDR分离株进行棋盘试验,以确定SiO₂@AgNPs与环丙沙星、美罗培南和头孢他啶-阿维巴坦之间的协同作用。采用透射电子显微镜(TEM)、傅里叶变换红外光谱(FTIR)和x射线衍射(XRD)对合成的纳米颗粒进行了表征。在450份脓液样本中,鉴定出100株铜绿假单胞菌,其中13株为耐多药铜绿假单胞菌。SiO₂@AgNPs表现出有效的抗菌活性,对耐多药铜绿假单胞菌的MIC为500µg/mL。棋盘格试验显示与美罗培南和头孢他啶-阿维巴坦有较强的协同作用(FICI = 0.375),与环丙沙星有部分协同作用(FICI = 0.625-1.0625)。TEM显示平均尺寸为10 nm的球形颗粒,FTIR证实了sio2官能团,XRD显示了在无定形二氧化硅基体中的结晶银纳米颗粒。这些发现表明SiO₂@AgNPs对耐多药P. aeruginosa具有有效的抗菌活性,可以增强某些抗生素的疗效,突出了其在耐药菌株联合治疗中的潜力。●二氧化硅包覆银纳米颗粒有效抑制耐多药铜绿假单胞菌。●SiO₂@AgNPs增强美罗培南和头孢他啶-阿维巴坦的疗效。纳米颗粒-抗生素组合可能为治疗耐药感染提供新的策略。
{"title":"Harnessing silica-coated silver nanoparticles for combating multidrug-resistant Pseudomonas aeruginosa","authors":"Salma Banu. A, Jaya Lakshmi. S. S., Leela K. V., K. Mani Rahulan, Kaviyarasan. S","doi":"10.1007/s00253-025-13699-5","DOIUrl":"10.1007/s00253-025-13699-5","url":null,"abstract":"<p>Multidrug-resistant (MDR) <i>Pseudomonas</i><i> aeruginosa</i> poses a critical challenge in clinical settings because of its resistance to conventional antibiotics. This study investigated the antibacterial potential of silica-coated silver nanoparticles (SiO₂@AgNPs) against MDR <i>P. aeruginosa</i> and explored their synergistic interactions with selected antibiotics. A total of 450 pus samples were processed for bacterial isolation, and <i>P. aeruginosa</i> was identified using standard microbiological methods. MDR strains were confirmed using MIC-based VITEK antimicrobial susceptibility testing and RT-PCR for resistance genes. The antibacterial activity of the SiO₂@AgNPs was assessed using the microbroth dilution method. A checkerboard assay was conducted against MDR isolates to determine the synergy between SiO₂@AgNPs and ciprofloxacin, meropenem, and ceftazidime-avibactam. The synthesized nanoparticles were characterized using transmission electron microscopy (TEM), Fourier-transform infrared (FTIR) spectroscopy, and X-ray diffraction (XRD) analysis. Of the 450 pus samples, 100 <i>P. aeruginosa</i> isolates were identified, of which 13 were classified as MDR <i>P. aeruginosa</i>. SiO₂@AgNPs exhibited effective antibacterial activity, with an MIC of 500 µg/mL against MDR <i>P. aeruginosa</i>. Checkerboard assays demonstrated strong synergy with meropenem and ceftazidime-avibactam (FICI = 0.375) and partial synergy with ciprofloxacin (FICI = 0.625–1.0625). TEM revealed spherical particles with an average size of 10 nm, FTIR confirmed SiO₂ functional groups, and XRD revealed crystalline silver nanoparticles within an amorphous silica matrix. These findings indicate that SiO₂@AgNPs possess potent antibacterial activity against MDR <i>P. aeruginosa</i> and can enhance the efficacy of certain antibiotics, highlighting their potential in combination therapy against resistant strains.</p><p>● <i>Silica-coated silver nanoparticles effectively inhibited MDR P. aeruginosa.</i></p><p><i>● SiO₂@AgNPs enhance the efficacy of meropenem and ceftazidime-avibactam.</i></p><p>●<i> Nanoparticle-antibiotic combinations may offer new strategies for treating resistant infections.</i></p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.3,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12791054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145948504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-10DOI: 10.1007/s00253-025-13692-y
Gina Grimmer, Julia Muenzner, Maximillian Schmacht, Maria Angels Subirana, Iris H. Valido, Philip Nickl, Paul M. Dietrich, Ievgen S. Donskyi, Dirk Schaumlöffel, Martin Hageböck, Michael Mülleder, Markus Ralser, Hajo Haase, Martin Senz, Maria Maares, Claudia Keil
Nutritional supplements such as trace element-enriched yeasts are becoming increasingly popular to overcome the worldwide problem of zinc (Zn) deficiency. Unlike selenium-enriched yeast, which is already authorized in the European Union, Zn-enriched yeasts (ZnY) have not yet been approved for food purposes in the European Union, as their evaluation is still ongoing, demanding more comprehensive data regarding the Zn species present in ZnY. This study screens ten different industrial yeast strains regarding their Zn-enrichment quota, with further characterization of selected strains using spectroscopic and proteomic approaches. Microfermentation experiments on the industrial yeasts showed Zn levels spanning 0.06–51 pg/cell. Large-scale fermentation in bioreactors was carried out with two strains excelling in either biomass or Zn accumulation. A combination of inductively coupled plasma mass spectrometry (ICP-MS) and various spectroscopic methods confirmed the Zn enrichment, while suggesting that fractions of the Zn accumulated on the cell surface, with simultaneously high values of phosphorus being present. Speciation via X-ray absorption spectroscopy (XAS) analyses revealed that Zn species are transformed and Zn is coordinated to P-O-ligands and to amino acid ligands in both strains. Proteomic analysis showed that ZnY cells moved from a Zap1-governed Zn balance to an intracellular excess response, implying cellular Zn uptake. This study demonstrates that, in a Zn-excess medium, industrial yeast strains exhibit variability in Zn-accumulation capacity, cellular Zn-localization, and regulatory responses involving the expression of Zn-binding proteins. The presented findings contribute to optimizing industrial fermentation processes for producing Zn-rich yeast biomass and enhance the understanding of Zn regulation in yeast, aiding in the approval of Zn-enriched yeasts for supplements and novel food applications.
• Zn enrichment in yeasts is strongly time and strain dependent
• Zn proteome changes under Zn excess suggest that Zn is partly internalized in the yeast cells
• Beside proteins, phosphorous compounds seem to be Zn-binding ligands in Zn-enriched yeast
{"title":"Unlocking the Zn-enriching potential of industrial yeast strains—an experimental journey from metal analysis to proteomics","authors":"Gina Grimmer, Julia Muenzner, Maximillian Schmacht, Maria Angels Subirana, Iris H. Valido, Philip Nickl, Paul M. Dietrich, Ievgen S. Donskyi, Dirk Schaumlöffel, Martin Hageböck, Michael Mülleder, Markus Ralser, Hajo Haase, Martin Senz, Maria Maares, Claudia Keil","doi":"10.1007/s00253-025-13692-y","DOIUrl":"10.1007/s00253-025-13692-y","url":null,"abstract":"<p>Nutritional supplements such as trace element-enriched yeasts are becoming increasingly popular to overcome the worldwide problem of zinc (Zn) deficiency. Unlike selenium-enriched yeast, which is already authorized in the European Union, Zn-enriched yeasts (ZnY) have not yet been approved for food purposes in the European Union, as their evaluation is still ongoing, demanding more comprehensive data regarding the Zn species present in ZnY. This study screens ten different industrial yeast strains regarding their Zn-enrichment quota, with further characterization of selected strains using spectroscopic and proteomic approaches. Microfermentation experiments on the industrial yeasts showed Zn levels spanning 0.06–51 pg/cell. Large-scale fermentation in bioreactors was carried out with two strains excelling in either biomass or Zn accumulation. A combination of inductively coupled plasma mass spectrometry (ICP-MS) and various spectroscopic methods confirmed the Zn enrichment, while suggesting that fractions of the Zn accumulated on the cell surface, with simultaneously high values of phosphorus being present. Speciation via X-ray absorption spectroscopy (XAS) analyses revealed that Zn species are transformed and Zn is coordinated to P-O-ligands and to amino acid ligands in both strains. Proteomic analysis showed that ZnY cells moved from a Zap1-governed Zn balance to an intracellular excess response, implying cellular Zn uptake. This study demonstrates that, in a Zn-excess medium, industrial yeast strains exhibit variability in Zn-accumulation capacity, cellular Zn-localization, and regulatory responses involving the expression of Zn-binding proteins. The presented findings contribute to optimizing industrial fermentation processes for producing Zn-rich yeast biomass and enhance the understanding of Zn regulation in yeast, aiding in the approval of Zn-enriched yeasts for supplements and novel food applications.</p><p>• <i>Zn enrichment in yeasts is strongly time and strain dependent</i></p><p>• <i>Zn proteome changes under Zn excess suggest that Zn is partly internalized in the yeast cells</i></p><p>• <i>Beside proteins, phosphorous compounds seem to be Zn-binding ligands in Zn-enriched yeast</i></p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.3,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12791086/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145948517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}